REQUEST A DEMO
Total
USD $0.00
Search more companies

Gladys Evan Cure (Colombia)

Main Activities: Ship Building and Repairing
Full name: Gladys Evan Cure Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Gladys Evan Cure is an enterprise located in Colombia, with the main office in Cartagena. It operates in the Ship Building and Repairing industry. The company was established on August 19, 1999. It currently has a total number of 16 (2026) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 7.49% in 2025. During that time, Gladys Evan Cure’s total assets decreased by 3.05%. In 2025, Gladys Evan Cure’s net profit margin increased by 0.87%.

Headquarters
Calle 27 22 203 Segunda Avenida Barrio Manga
Cartagena; Bolivar;

Contact Details: Purchase the Gladys Evan Cure report to view the information.

Basic Information
Total Employees:
Purchase the Gladys Evan Cure report to view the information.
Financial Auditors:
Purchase the Gladys Evan Cure report to view the information.
Incorporation Date:
August 19, 1999
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Gladys Evan Cure report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
7.49%
Total Operating Revenue
7.49%
Operating Profit
10.66%
Net Profit/Loss for the Period
16.25%
Total Assets
-3.05%
Total Equity
-20.27%
Operating Profit Margin
0.15%
Net Profit Margin
0.87%
Return on Equity (ROE)
5.82%
Quick Ratio
-0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?